Global Sexually Transmitted Diseases (STDs) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212310039 | Category: Pharma & Healthcare | Pages: 106 | Format: PDF | Published Date: January 30,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Sexually Transmitted Diseases (STDs) Drug market size was valued at USD 21640 million in 2022 and is forecast to a readjusted size of USD 38580 million by 2029 with a CAGR of 8.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Sexually Transmitted Diseases (STDs) Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Sexually Transmitted Diseases (STDs) Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Sexually Transmitted Diseases (STDs) Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Sexually Transmitted Diseases (STDs) Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Sexually Transmitted Diseases (STDs) Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sexually Transmitted Diseases (STDs) Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sexually Transmitted Diseases (STDs) Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Hoffmann La Roche, Bayer Healthcare, Eli Lilly and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Sexually Transmitted Diseases (STDs) Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Chlamydia
    Gonorrhea
    Syphilis
    Genital herpes
    HPV
    HIV / AIDS
Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
Major players covered
    Pfizer
    Hoffmann La Roche
    Bayer Healthcare
    Eli Lilly
    Johnson & Johnson
    Bristol-Myers Squibb
    AbbVie, Inc.
    Gilead Sciences
    GlaxoSmithKline Plc
    Merck & Co., Inc.
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sexually Transmitted Diseases (STDs) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sexually Transmitted Diseases (STDs) Drug, with price, sales, revenue and global market share of Sexually Transmitted Diseases (STDs) Drug from 2018 to 2023.
Chapter 3, the Sexually Transmitted Diseases (STDs) Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sexually Transmitted Diseases (STDs) Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Sexually Transmitted Diseases (STDs) Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sexually Transmitted Diseases (STDs) Drug.
Chapter 14 and 15, to describe Sexually Transmitted Diseases (STDs) Drug sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Sexually Transmitted Diseases (STDs) Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Sexually Transmitted Diseases (STDs) Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Chlamydia
        1.3.3 Gonorrhea
        1.3.4 Syphilis
        1.3.5 Genital herpes
        1.3.6 HPV
        1.3.7 HIV / AIDS
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Sexually Transmitted Diseases (STDs) Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Sexually Transmitted Diseases (STDs) Drug Market Size & Forecast
        1.5.1 Global Sexually Transmitted Diseases (STDs) Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Sexually Transmitted Diseases (STDs) Drug Sales Quantity (2018-2029)
        1.5.3 Global Sexually Transmitted Diseases (STDs) Drug Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.1.4 Pfizer Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments/Updates
    2.2 Hoffmann La Roche
        2.2.1 Hoffmann La Roche Details
        2.2.2 Hoffmann La Roche Major Business
        2.2.3 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.2.4 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Hoffmann La Roche Recent Developments/Updates
    2.3 Bayer Healthcare
        2.3.1 Bayer Healthcare Details
        2.3.2 Bayer Healthcare Major Business
        2.3.3 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.3.4 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bayer Healthcare Recent Developments/Updates
    2.4 Eli Lilly
        2.4.1 Eli Lilly Details
        2.4.2 Eli Lilly Major Business
        2.4.3 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.4.4 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Eli Lilly Recent Developments/Updates
    2.5 Johnson & Johnson
        2.5.1 Johnson & Johnson Details
        2.5.2 Johnson & Johnson Major Business
        2.5.3 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.5.4 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Johnson & Johnson Recent Developments/Updates
    2.6 Bristol-Myers Squibb
        2.6.1 Bristol-Myers Squibb Details
        2.6.2 Bristol-Myers Squibb Major Business
        2.6.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.6.4 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bristol-Myers Squibb Recent Developments/Updates
    2.7 AbbVie, Inc.
        2.7.1 AbbVie, Inc. Details
        2.7.2 AbbVie, Inc. Major Business
        2.7.3 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.7.4 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 AbbVie, Inc. Recent Developments/Updates
    2.8 Gilead Sciences
        2.8.1 Gilead Sciences Details
        2.8.2 Gilead Sciences Major Business
        2.8.3 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.8.4 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Gilead Sciences Recent Developments/Updates
    2.9 GlaxoSmithKline Plc
        2.9.1 GlaxoSmithKline Plc Details
        2.9.2 GlaxoSmithKline Plc Major Business
        2.9.3 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.9.4 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 GlaxoSmithKline Plc Recent Developments/Updates
    2.10 Merck & Co., Inc.
        2.10.1 Merck & Co., Inc. Details
        2.10.2 Merck & Co., Inc. Major Business
        2.10.3 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Product and Services
        2.10.4 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Merck & Co., Inc. Recent Developments/Updates
3 Competitive Environment: Sexually Transmitted Diseases (STDs) Drug by Manufacturer
    3.1 Global Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Sexually Transmitted Diseases (STDs) Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Sexually Transmitted Diseases (STDs) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Sexually Transmitted Diseases (STDs) Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Sexually Transmitted Diseases (STDs) Drug Manufacturer Market Share in 2022
    3.5 Sexually Transmitted Diseases (STDs) Drug Market: Overall Company Footprint Analysis
        3.5.1 Sexually Transmitted Diseases (STDs) Drug Market: Region Footprint
        3.5.2 Sexually Transmitted Diseases (STDs) Drug Market: Company Product Type Footprint
        3.5.3 Sexually Transmitted Diseases (STDs) Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size by Region
        4.1.1 Global Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Sexually Transmitted Diseases (STDs) Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Sexually Transmitted Diseases (STDs) Drug Average Price by Region (2018-2029)
    4.2 North America Sexually Transmitted Diseases (STDs) Drug Consumption Value (2018-2029)
    4.3 Europe Sexually Transmitted Diseases (STDs) Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Consumption Value (2018-2029)
    4.5 South America Sexually Transmitted Diseases (STDs) Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Sexually Transmitted Diseases (STDs) Drug Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Type (2018-2029)
    5.2 Global Sexually Transmitted Diseases (STDs) Drug Consumption Value by Type (2018-2029)
    5.3 Global Sexually Transmitted Diseases (STDs) Drug Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Application (2018-2029)
    6.2 Global Sexually Transmitted Diseases (STDs) Drug Consumption Value by Application (2018-2029)
    6.3 Global Sexually Transmitted Diseases (STDs) Drug Average Price by Application (2018-2029)
7 North America
    7.1 North America Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Type (2018-2029)
    7.2 North America Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Application (2018-2029)
    7.3 North America Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        7.3.1 North America Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Sexually Transmitted Diseases (STDs) Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        8.3.1 Europe Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Sexually Transmitted Diseases (STDs) Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Market Size by Region
        9.3.1 Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Sexually Transmitted Diseases (STDs) Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Type (2018-2029)
    10.2 South America Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Application (2018-2029)
    10.3 South America Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        10.3.1 South America Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Sexually Transmitted Diseases (STDs) Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Market Size by Country
        11.3.1 Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Sexually Transmitted Diseases (STDs) Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Sexually Transmitted Diseases (STDs) Drug Market Drivers
    12.2 Sexually Transmitted Diseases (STDs) Drug Market Restraints
    12.3 Sexually Transmitted Diseases (STDs) Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Sexually Transmitted Diseases (STDs) Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Sexually Transmitted Diseases (STDs) Drug
    13.3 Sexually Transmitted Diseases (STDs) Drug Production Process
    13.4 Sexually Transmitted Diseases (STDs) Drug Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Sexually Transmitted Diseases (STDs) Drug Typical Distributors
    14.3 Sexually Transmitted Diseases (STDs) Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Sexually Transmitted Diseases (STDs) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?